EMD-28190

Single-particle
3.89 Å
EMD-28190
3D View Gallery
Deposition: 19/09/2022
Map released: 28/12/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-28190
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

SARS-CoV-2 RBD in complex with biparatopic nanobody BP10 local refinement

EMD-28190

Single-particle
3.89 Å
EMD-28190
3D View Gallery
Deposition: 19/09/2022
Map released: 28/12/2022
Last modified: 28/12/2022
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Sample: SARS-CoV-2 Spike in complex with biparatopic nanobody BP10

Deposition Authors: Pymm PG, Glukhova A , Tham WH
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2.
Pymm P, Redmond SJ, Dolezal O , Mordant F, Lopez E , Cooney JP, Davidson KC, Haycroft ER , Tan CW, Seneviratna R, Grimley SL, Purcell DFJ, Kent SJ, Wheatley AK, Wang LF, Leis A, Glukhova A , Pellegrini M , Chung AW , Subbarao K, Uldrich AP , Tham WH , Godfrey DI, Gherardin NA
(2022) iScience , 25 , 105259 - 105259
PUBMED: 36213007
DOI: doi:10.1016/j.isci.2022.105259
ISSN: 2589-0042